相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Patricia Huezo-Diaz et al.
CURRENT DRUG METABOLISM (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients
M. Ansari et al.
BONE MARROW TRANSPLANTATION (2013)
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry
Marc Ansari et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2012)
Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children: The Results of a Population Pharmacokinetic Study From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation
Angelo Paci et al.
THERAPEUTIC DRUG MONITORING (2012)
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes
J. Perkins et al.
BONE MARROW TRANSPLANTATION (2011)
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
A. B. M. Madureira et al.
LEUKEMIA (2011)
Influence of GST gene polymorphisms on busulfan pharmacokinetics in children
M. Ansari et al.
BONE MARROW TRANSPLANTATION (2010)
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
Joseph Pidala et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Impact of Conditioning Regimen in Allogeneic Hematopoetic Stem Cell Transplantation for Children with Acute Myelogenous Leukemia beyond First Complete Remission: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study
India Y. Sisler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation
Imke H. Bartelink et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant
W. T. Tse et al.
BONE MARROW TRANSPLANTATION (2009)
IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant:: Limited sampling strategies
L. Lee Dupuis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation
Imke H. Bartelink et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Glutathione S-transferase A1 genetic variants reduce Busulfan clearance in children undergoing hematopoietic cell transplantation
L'Aurelle Johnson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: Pharmacokinetics, liver toxicity, and mortality
Jeannine S. McCune et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
Inho Kim et al.
CLINICAL TRANSPLANTATION (2007)
Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity
J Zwaveling et al.
BONE MARROW TRANSPLANTATION (2005)
I. V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients
L Nguyen et al.
BONE MARROW TRANSPLANTATION (2004)
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis
G Michel et al.
BLOOD (2003)
Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results
JH Dalle et al.
BONE MARROW TRANSPLANTATION (2003)
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation
JS McCune et al.
BONE MARROW TRANSPLANTATION (2002)
Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for IV BuCy2 in chronic myelogenous leukemia
BS Andersson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
N Bleyzac et al.
BONE MARROW TRANSPLANTATION (2001)
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation
EA Copelan et al.
BONE MARROW TRANSPLANTATION (2001)
Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia
KS Baker et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
